The ethics of the placebo in clinical practice

Journal of Medical Ethics

Volumn 30, Issue 6, 2004, Pages 551-554

  Lichtenberg, P ^a   Heresco Levy, U ^a   Nitzan, U ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; PETHIDINE; PLACEBO; SODIUM CHLORIDE;

ABDOMINAL CRAMP; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONDITIONING; DEPRESSION; DIARRHEA; GASTROENTERITIS; HUMAN; LEG AMPUTATION; MEDICAL ETHICS; MORALITY; PAIN; PRACTICE GUIDELINE; RECUMBENCY;

HEALTH CARE AND PUBLIC HEALTH;

ADULT; ATTITUDE OF HEALTH PERSONNEL; ETHICS, CLINICAL; FAMILY PRACTICE; FEMALE; HUMANS; MALE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS;

EID: 11144286477     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2002.002832     Document Type: Article

References (21)

1. Shapiro AK, Shapiro E. The powerful placebo: from ancient priest to modern physician. Baltimore and London: Johns Hopkins University Press, 1997.
2. Emanuel EJ, Miller FG. The ethics of placebo controlled trials: a middle ground. N Engl J Med 2001;345:915-19.
3. Gotzsche PC. Is there logic in the placebo? Lancet 1994;344:925-6.
4. Shepherd M. The placebo: from specificity to the non-specific and back. Psychol Med 1993;23:569-78.
5. Kaptchuk TJ. Powerful placebo: The dark side of the randomised controlled trial. Lancet 1998;351:1722-5.
6. Amanzio M. Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation activated opioid systems versus conditioning activated specific subsystems. J Neurosci 1999; 19 484-94.
7. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002;136 471-6.
8. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-36.
9. Johnson AG. Surgery as a placebo. Lancet 1994; 344:1140-2.
10. Bienenfeld L, Frishman W, Glasser SP. The placebo effect in cardiovascular disease. Am Heart J 1996;132 1207-21.
11. Laporte J, Figueras A. Placebo effects in psychiatry. Lancet 1994;344:1206-9.
12. Thomas KB. The placebo in general practice. Lancet 1994;344:1066-7.
13. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-602.
14. Bailar JC. The powerful placebo and the wizard of Oz. N Engl J Med 2001;344:1630-2.
15. Kirsch I, Scorboria A. Apples, oranges, and placebos: heterogeneity in a meta-analysis of placebo effects. Adv Mind Body Med 2001;17:309-12.
16. Benedetti F, Amanzio M, Baldi S, et al. Inducing placebo respiratory responses in humans via opioid receptors. Eur J Neurosci 1999;11:625-31.
17. De la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Placebo effect in Parkinson's disease. Science 2001;293 1164-6.
18. De Craen AJM, Roos PJ, de Vries AL, et al. Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness. BMJ 1996;313:1624-6.
19. De Deyn PP, d'Hooge R. Placebos in clinical practice and research. J Med Ethics 1996;22:140-6.
20. Park LC, Covi L. Non-blind placebo trial. An exploration of neurotic patients' responses to placebo when its inert content is disclosed. Arch Gen Psychiatry 1965;12:336-45.
21. Spiro H. Clinical reflections on the placebo phenomenon. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge, MA: Harvard University Press, 1997:37-55.